Pixantrone (Pixuvri)
Revision as of 17:29, 25 July 2017 by Warner-admin (talk | contribs) (Text replacement - "Category:Intravenous chemotherapy" to "Category:Intravenous medications")
Although this drug is EMA approved as of 5/31/2013, it is not yet FDA approved.
Mechanism of action
From the NCI Drug Dictionary: The dimaleate salt of a synthetic, noncardiotoxic aza-anthracenedione analogue with potential antineoplastic activity. Pixantrone intercalates into DNA and induces topoisomerase II-mediated DNA strand crosslinks, resulting in inhibition of DNA replication and tumor cell cytotoxicity. Route: IV
Diseases for which it is used
Also known as
BBR 2778, Pixantrone dimaleate